Table 3 Progression-free and overall survival by patient race-ethnicity

From: Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Race-ethnicity

Progression-free survival

Overall survival

 

N

(events/patients)

Median (years)

(95% CI)a

N

(events/patients)

Median (years)

(95% CI)a

Non-Hispanic White

1960/2373

2.0 (1.9, 2.1)

1466/2373

4.2 (4.0, 4.4)

Non-Hispanic African-American

314/392

1.9 (1.7, 2.1)

232/392

4.3 (3.8, 4.8)

Hispanic

60/76

2.7 (1.7, 3.0)

50/76

4.0 (3.2, 4.9)

Non-Hispanic other

41/55

1.2 (0.6, 1.9)

34/55

3.3 (2.3, 4.4)

  1. CI confidence interval